06.03.2013 • News • Arkema • Specialchem • chemical industry

Arkema Starts Commercial Acceleration Program with SpecialChem

Arkema has selected SpecialChem's Commercial Acceleration Solutions to support the global growth of its water-based fluoropolymer Kynar Aquatec latex in the exterior building and construction markets.

As part of its commercial acceleration program, SpecialChem will support Arkema in its business development strategy for Kynar Aquatec latex in the exterior building and construction market. SpecialChem's customized Commercial Acceleration Solutions will help bring speed and market reach, acting as an extension of Arkema's business development team. The purpose of this collaboration is to educate paints and coatings formulators and architects about the benefits of Kynar Aquatec latex and to identify active projects at formulators and end-users.

 

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

Top-Feature

most read